This work developed a predictive and therapeutic assessment score for lysosomes based on four major lysosomal genes (CTSV, LAPTM4B, DNAJC6 and AP1M2), opening up new avenues for enhancing the efficiency and accuracy of HCC diagnosis and therapy. This evidence concerns the gene LAPTM4B and hepatocellular carcinoma.